Terry Mcguire

Biography

Terry McGuire is a Founding Partner of Polaris Partners and brings more than 25 years of successful early-stage investing experience to the healthcare industry. As a venture capitalist, he has invested in more than 48 companies, co-founding three: Microchips Biotech, Inspire Pharmaceuticals and Advanced Inhalation Research. Mr. McGuire serves on the boards of Polaris-backed companies 480 Biomedical; The Gerngross Companies (Adimab, Arsanis & Allector); Iora Health; Microchips Biotech; Nextcode Health; Pulmatrix; Quantum Designs; SustainX, Acceleron (XLRN) and Ironwood Pharmaceuticals (IRWD). Mr. McGuire also chairs the Board of Overseers of the Thayer School of Engineering, Dartmouth College, and serves on the boards of MIT’s David Koch Institute for Integrative Cancer Research, the Arthur Rock Center for Entrepreneurship, Harvard Business School; and the Scientific Advisory Board at Brigham & Women’s Hospital. He is the founder and chairman of the Global Venture Capital Congress and Chairman Emeritus of the National Venture Capital Association. Mr. McGuire holds an MBA from Harvard Business School, a Master of Science in engineering from The Thayer School at Dartmouth College, and a Bachelor of Science in physics and economics from Hobart College. 

Research Interest

Healthcare industry, Business Development